NAMS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

NAMSNewAmsterdam Pharma Co N.V.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

NAMSNewAmsterdam Pharma Co N.V.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

NAMSwithLLY

No shared trading history for NAMS and LLY.

Shared co-movers: not yet measured (NAMS).

NAMS, solidLLY, hatchedr = correlationBar = r to r 0.75Source: daily closes

NAMSNewAmsterdam Pharma Co N.V.

18.90▲+0.05%· post 18.80· delayed

Mkt cap$2.3BRevenue$19MQ3 FY26Revenue$23MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,361.79· delayed

After hoursNov 6 '26delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 6 '26delayed

NAMSNewAmsterdam Pharma Co N.V.

LLYELI Lilly & Co

18.90▲+0.05%post 18.80delayed

Price

1,360.90▼−0.28%post 1,361.79delayed

$2.3B

Mkt cap

$1.2T

Q3 FY26$19M

Revenue

$24.4BQ3 FY26

FY25$23M

Revenue

$65.2BFY25

NAMS18.90▲+0.05%vsLLY1,360.90▼−0.28%After hoursNov 6 '26delayed